196 related articles for article (PubMed ID: 25129477)
1. Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice.
Krzyzowska M; Orłowski P; Bąska P; Bodera P; Zdanowski R; Stankiewicz W
Immunobiology; 2014 Dec; 219(12):932-43. PubMed ID: 25129477
[TBL] [Abstract][Full Text] [Related]
2. Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.
Krzyzowska M; Baska P; Grochowska A; Orlowski P; Nowak Z; Winnicka A
Immunobiology; 2014 Jan; 219(1):64-77. PubMed ID: 24028839
[TBL] [Abstract][Full Text] [Related]
3. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
4. A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.
Bień K; Sobańska Z; Sokołowska J; Bąska P; Nowak Z; Winnicka A; Krzyzowska M
Arch Virol; 2016 Apr; 161(4):913-28. PubMed ID: 26780774
[TBL] [Abstract][Full Text] [Related]
5. Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
Bień K; Sokołowska J; Bąska P; Nowak Z; Stankiewicz W; Krzyzowska M
Mediators Inflamm; 2015; 2015():281613. PubMed ID: 25873756
[TBL] [Abstract][Full Text] [Related]
6. Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection.
Krzyzowska M; Shestakov A; Eriksson K; Chiodi F
Cell Death Dis; 2011 Mar; 2(3):e132. PubMed ID: 21412278
[TBL] [Abstract][Full Text] [Related]
7. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
8. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
9. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
10. Pathological effect of IL-17A-producing TCRγδ(+) T cells in mouse genital mucosa against HSV-2 infection.
Kim JO; Cha HR; Kim ED; Kweon MN
Immunol Lett; 2012 Sep; 147(1-2):34-40. PubMed ID: 22698680
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas.
Fogler WE; Volker K; Watanabe M; Wigginton JM; Roessler P; Brunda MJ; Ortaldo JR; Wiltrout RH
J Immunol; 1998 Dec; 161(11):6014-21. PubMed ID: 9834083
[TBL] [Abstract][Full Text] [Related]
12. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
Elife; 2021 May; 10():. PubMed ID: 34047696
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Fas/FasL pathway in the murine model of atopic dermatitis.
Bień K; Żmigrodzka M; Orłowski P; Fruba A; Szymański Ł; Stankiewicz W; Nowak Z; Malewski T; Krzyżowska M
Inflamm Res; 2017 Aug; 66(8):679-690. PubMed ID: 28434120
[TBL] [Abstract][Full Text] [Related]
14. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
Tsunobuchi H; Nishimura H; Goshima F; Daikoku T; Suzuki H; Nakashima I; Nishiyama Y; Yoshikai Y
Virology; 2000 Sep; 275(1):57-66. PubMed ID: 11017787
[TBL] [Abstract][Full Text] [Related]
15. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
16. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
18. Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammation.
Fernandes P; O'Donnell C; Lyons C; Keane J; Regan T; O'Brien S; Fallon P; Brint E; Houston A
J Immunol; 2014 Dec; 193(12):6103-13. PubMed ID: 25378591
[TBL] [Abstract][Full Text] [Related]
19. Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation.
Krzyzowska M; Kowalczyk A; Skulska K; Thörn K; Eriksson K
Front Immunol; 2021; 12():714821. PubMed ID: 34526992
[TBL] [Abstract][Full Text] [Related]
20. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
